Dimension Therapeutics, Inc
DMTX
DMTX was delisted on the 6th of November, 2017.
0 hedge funds and large institutions have $0 invested in Dimension Therapeutics, Inc in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 34 closing their positions.
100% less funds holding
Funds holding: 34 → 0 (-34)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $109M → $0 (-$109M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 34
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$32.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.4M |
| 3 |
NLVP
New Leaf Venture Partners
New York
|
-$12.4M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$10.1M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$7.51M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SIM
26
Spark Investment Management
New York
| – | -$118K | -19,729 | Closed |
|
27
Morgan Stanley
New York
| – | -$115K | -19,072 | Closed |
|
28
State Street
Boston,
Massachusetts
| – | -$97K | -16,100 | Closed |
|
29
Wells Fargo
San Francisco,
California
| – | -$76K | -12,592 | Closed |
|
30
Bank of America
Charlotte,
North Carolina
| – | -$63K | -10,501 | Closed |
|
31
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$19K | -3,231 | Closed |
|
|
MAM
32
Meeder Asset Management
Dublin,
Ohio
| – | -$4K | -593 | Closed |
|
33
UBS Group
Zurich,
Switzerland
| – | -$1K | -113 | Closed |
|
DMTX Hedge Fund Activity: Q4 2017 in Review
0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q4 2017, worth a combined $0 — down 100% from $109M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of DMTX and 0 opened new positions — a net loss of 34 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was OrbiMed, exiting entirely with an estimated $32.4M sold.
- 0 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q4 2017, down from 34 in Q3 2017.
- Funds reported $0 of Dimension Therapeutics, Inc stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new Dimension Therapeutics, Inc positions in Q4 2017 and 34 closed out, a net change of -34 holders.
- The largest Dimension Therapeutics, Inc seller in Q4 2017 was OrbiMed, an estimated $32.4M sold.
Based on aggregated 13F filings for Q4 2017.